Jonathan Cheong
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
-
- Computational Drug Discovery Methods
Papers in
- Co-authors
- Lori H. Takahashi (1 shared paper)Harold E. Selick (1 shared paper)John W. Tolan (1 shared paper)Emile G. Plise (9 shared papers)Laurent Salphati (7 shared papers)Jae Hoon Chang (4 shared papers)Jeniel E. Nett (2 shared papers)Lindsay Kalan (4 shared papers)
- Journals
- Drug Metabolism and Disposition (6 papers)Xenobiotica (4 papers)Molecular Pharmaceutics (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)International Journal of Pharmaceutics (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Jonathan Cheong
31 papers receiving 2.2k citations
Jonathan Cheong's Hit Papers
Peers
Comparison fields: 5 of 89
- Pharmaceutical Science 239
- Computational Theory and Mathematics 336
- Oncology 377
- Infectious Diseases 309
- Pharmacology 139
Countries citing papers authored by Jonathan Cheong
This map shows the geographic impact of Jonathan Cheong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Cheong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Cheong more than expected).
Fields of papers citing papers by Jonathan Cheong
This network shows the impact of papers produced by Jonathan Cheong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Cheong. The network helps show where Jonathan Cheong may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Cheong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening Hit paper breakdown → | 1999 | 817 |
| 2 | Novel antibody–antibiotic conjugate eliminates intracellular S. aureus Hit paper breakdown → | 2015 | 726 |
| 3 | 2020 | 128 | |
| 4 | 2016 | 89 | |
| 5 | 2012 | 64 | |
| 6 | 2013 | 59 | |
| 7 | 2019 | 57 | |
| 8 | 2012 | 50 | |
| 9 | 2018 | 48 | |
| 10 | 2016 | 46 | |
| 11 | 2016 | 40 | |
| 12 | 2015 | 35 | |
| 13 | 2014 | 26 | |
| 14 | 2010 | 25 | |
| 15 | 2014 | 20 | |
| 16 | 2020 | 19 | |
| 17 | 2011 | 13 | |
| 18 | 2022 | 10 | |
| 19 | 2017 | 9 | |
| 20 | 2019 | 9 |
About Jonathan Cheong
Jonathan Cheong is a scholar working on Oncology, Genetics, Pharmacology, Molecular Biology and Pharmacology, having authored 33 papers that have together received 2.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (13 papers), Glioma Diagnosis and Treatment (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Computational Drug Discovery Methods (3 papers), Drug Solubulity and Delivery Systems (2 papers), Antifungal resistance and susceptibility (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Pharmaceutical Science (239 citations), Computational Theory and Mathematics (336 citations), Oncology (377 citations), Infectious Diseases (309 citations) and Pharmacology (139 citations). Jonathan Cheong has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Lori H. Takahashi, Harold E. Selick, John W. Tolan, Emile G. Plise, Laurent Salphati, Jae Hoon Chang, Jeniel E. Nett, Lindsay Kalan, Chad J Johnson and Dhanansayan Shanmuganayagam. Their work appears in journals such as Drug Metabolism and Disposition, Xenobiotica, Molecular Pharmaceutics, Bioorganic & Medicinal Chemistry Letters and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.